Coloplast expands its Luja™ portfolio with next generation catheter for women
14 May 2024 - 5:30PM
Coloplast expands its Luja™ portfolio with next generation catheter
for women
The female intermittent catheter enables complete bladder
emptying in one free flow1, aiming to reduce the risk of urinary
tract infections2.
Following the successful launch of Luja with Micro-hole Zone
Technology, a next generation intermittent catheter for men,
Coloplast is now launching Luja for women.
“So far, we have received great feedback on Luja for men in our
product evaluations. Nearly all healthcare professionals would
recommend the male catheter to their patients3, and seven out of
ten users feel confident that it empties their bladder completely
without needing to reposition the catheter4,” says Nicolai Buhl,
Executive Vice President of Innovation.
Urinary tract infections remain a major concern and challenge
for men and women using catheters5. Flow stops and blockage of
conventional catheter eyelets during catheterisation increase the
risk of leaving residual urine behind in the bladder, which raises
the risk of bacteria growth and is a well-known UTI risk
factor2.
“I am excited that the Micro-hole Zone Technology will now be
available for female catheter users. The new female catheter has
50+ micro-holes*, enabling complete bladder emptying in one free
flow1, and I believe this technology will set a completely
new standard in the market,” says Nicolai Buhl.
Luja with Micro-hole Zone Technology for female users will
launch across all Coloplast’s key markets over the next 12 months,
starting in Denmark and Italy in May 2024**.
Clinical studies: No need for repositioning and no
discomfortThe performance of Luja for women is supported by two
clinical studies. The studies found that the catheter enables
complete bladder emptying in one free flow without having to
reposition the catheter1. The studies also found that women
reported no discomfort when using Luja and that the catheter was
gentle to use6.
Reduced environmental footprintLuja Female is designed
with the user and environment in mind. The catheter is made with
28% less plastic than Coloplast’s SpeediCath® Compact Eve and has a
22% lower carbon footprint7. The Luja Female product container
material is recyclable8.
ContactsPeter MønsterSr. Media Relations Manager+45 4911
2623dkpete@coloplast.com
Aleksandra DimovskaSr. Director of Investor Relations+45 4911
2458dkadim@coloplast.com
References1Luja female ensured zero flow stops in 87% of
catheterisations & <10 mL residual urine at first flow stop
in 83% of catheterisations (RCTs, post-hoc, NCT05841004, n=73,
& NCT05814211, n=82). Coloplast Data-on-File, 01/2024.
Individualresults may vary.
2UTI risk factors defined by Kennelly M, Thiruchelvam N,
Averbeck MA et al. Adult Neurogenic Lower Urinary Tract Dysfunction
and Intermittent Catheterisation in a Community Setting: Risk
Factors Model for Urinary Tract Infections, Adv Urol., 2019;
2:2019:2757862
3Vaabengaard R, Islamoska S, Zeeberg R, Jacobsen L. Healthcare
professionals feel confident and less worried about bladder
emptying and urinary tract infections when patients use the
micro-hole zone catheter Luja™. BAUN Annual Conference, AAC,
Liverpool, UK 2023. PM-28201, n = 62.
4Vaabengaard R, Islamoska S, Zeeberg R, Jacobsen L. Users of
intermittent catheters feel more confidence and less worries of
bladder emptying and urinary tract infections when using the
micro-hole zone catheter Luja™. BAUN Annual Conference, AAC,
Liverpool, UK 2023. PM-28203, n = 816.
5Averbeck MA, Kennelly M, Thiruchelvam N et al. Risk factors for
urinary tract infections associated with lower quality of life
among intermittent catheter users. British Journal of Nursing,
2023, Vol 32, No 18 (Urology Supplement).
6Coloplast Data-on-File, RCT, NCT05814211, 03/2024, n=82
7Compared to SpeediCath® Compact Eve. Based on externally
reviewed carbon footprint according to ISO14067.
8Product design, use and local waste management specifics may
limit recyclability.
*minimum of 50 micro-holes on Luja female CH10-16. **Luja for
female users is a medical device for which the CE-mark has been
affixed. Product availability is subject to the regulatory process
of individual countries and is not guaranteed. The product is
currently not available in the US.
Coloplast AS (TG:CBHD)
Historical Stock Chart
From Oct 2024 to Nov 2024
Coloplast AS (TG:CBHD)
Historical Stock Chart
From Nov 2023 to Nov 2024